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Abstract
Object Imaging of myocardial infarct composition is
essential to assess efficacy of emerging therapeutics. T2
*
mapping has the potential to image myocardial hemorrhage
and fibrosis by virtue of its short T2
*. We aimed to quantify
T2
* in acute and chronic myocardial ischemia/reperfusion
(I/R) injury in mice.
Materials and methods I/R-injury was induced in
C57BL/6 mice (n = 9). Sham-operated mice (n = 8)
served as controls. MRI was performed at baseline, and 1, 7
and 28 days after surgery. MRI at 9.4 T consisted of Cine,
T2
* mapping and late-gadolinium-enhancement (LGE).
Mice (n = 6) were histologically assessed for hemorrhage
and collagen in the fibrotic scar.
Results Baseline T2
* values were 17.1 ± 2.0 ms. At day 1,
LGE displayed a homogeneous infarct enhancement. T2
*
in infarct (12.0 ± 1.1 ms) and remote myocardium
(13.9 ± 0.8 ms) was lower than at baseline. On days 7 and
28, LGE was heterogeneous. T2
* in the infarct decreased to
7.9 ± 0.7 and 6.4 ± 0.7 ms, whereas T2
* values in the
remote myocardium were 14.2 ± 1.1 and 15.6 ± 1.0 ms.
Histology revealed deposition of iron and collagen in
parallel with decreased T2
*.
Conclusion T2
* values are dynamic during infarct devel-
opment and decrease significantly during scar maturation.
In the acute phase, T2
* values in infarcted myocardium
differ significantly from those in the chronic phase. T2
*
mapping was able to confirm the presence of a chronic
infarction in cases where LGE was inconclusive. Hence, T2
*
may be used to discriminate between acute and chronic
infarctions.
Keywords Cardiovascular magnetic resonance 
Myocardial infarction  T2*  LGE  Mouse  Fibrosis 
Hemorrhage
Introduction
Despite recent advances in therapeutics and diagnostics,
morbidity and mortality after myocardial infarction (MI)
remains a great socio-economic burden in Western socie-
ties. Early identification of patients with sub-optimal car-
diac recovery is of great importance to improve clinical
management. For this reason, both functional and structural
characterization of the infarcted myocardium is important
for risk stratification of patients after MI.
Technological advances in cardiovascular magnetic
resonance (CMR) have demonstrated different ways to
track and characterize MI at different time points [1–6].
CMR has been applied to analyze inflammation, edema,
necrosis, fibrosis, left-ventricular (LV) remodeling and
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metabolism in MI [7–15]. Pathological changes in the
injured myocardium, such as the presence of fibrosis,
hemorrhage and edema, influence the signal intensity on
T1-and T2-weighted imaging [7, 16–18]. CMR is thus
considered as one of the most important imaging tools in
the assessment of the heart after MI.
Typically, T1-weighted imaging is performed some time
after injecting a gadolinium-based contrast agent to delin-
eate injured myocardium in a late gadolinium enhancement
(LGE) scan [19]. The enhancement mechanism of infarcted
tissue is related to the extent of the extracellular volume,
which is associated with the delayed washout relative to the
healthy myocardium. LGE is widely used and, without
competition, considered the gold standard to assess infarct
size. Nevertheless, there are certain limitations of LGE
related to pathological processes after the onset of infarc-
tion. In the acute and sub-acute phase after successful
reperfusion of the ischemic myocardium, the transmural
infarct extent is not stable and an overestimation of infarct
size has been reported [20]. In the chronic phase, excessive
and heterogeneous collagen deposition during scar matu-
ration may hamper signal enhancement by LGE.
In view of the above limitations, several alternative
contrast mechanisms are explored to study the pathophys-
iological changes in the injured myocardium. The sensi-
tivity of the T2 relaxation time to myocardial water content
has led to the application of T2-weighted CMR protocols to
image myocardial edema as an indicator of inflammation
and necrosis in acute MI [13, 15, 21–24]. T2
* contrast has
been explored as a tool to diagnose the presence of hem-
orrhage and myocardial iron [1–5, 25–28]. Recently, it was
demonstrated that T2
* has the potential to image fibrosis in
the infarct zone using an ultra-short echo time (UTE)
technique [29].
In this paper, we hypothesize that the structural and
pathological changes in acute and chronic MI, such as the
presence and development of myocardial hemorrhage and
fibrotic tissue progressively influence T2
* values in the
infarcted myocardium. To investigate this, we quantified T2
*
using a T2
*-mapping protocol longitudinally in acute and
chronic ischemia/reperfusion (I/R) infarcts in mice. We
explored the utility of T2
* mapping as a complementary tool
to LGE to characterize the infarcted myocardium.
Materials and methods
Experimental design
C57Bl6/J mice (n = 23, body weight = 20–25 g) were
used in this study. CMR measurements were performed at
baseline (BL), 1 day (acute infarct), 7 and 28 days (chronic
infarct) after induction of MI by 30 min transient ligation
of the left coronary artery (LCA) (n = 9). A sham-operated
group (n = 8) served as control. The CMR protocol for the
infarct group consisted of a multi-gradient-echo quantita-
tive T2
*-mapping sequence, traditional LGE to assess the
location and size of the infarct, and gradient-echo Cine
imaging to determine cardiac function. The sham-operated
(control) group underwent gradient-echo Cine imaging
only to evaluate cardiac function. In the first group of nine
mice with MI, one mouse died at day 28 during the CMR
scan. Another three mice of this group presented a small
infarct on LGE images at day 1, but no chronic myocardial
infarct at day 7 and 28 (as exemplified in Fig. 3). A sep-
arate set of mice with MI (n = 6) were killed either at day
1 (n = 2), 7 (n = 2), or 28 (n = 2) for the histopatholo-
gical characterization of myocardial tissues. All animal
experiments were performed in accordance with the
national guidelines on animal care and with prior approval
by the Animal Experimentation Committee of Utrecht
University.
Mouse model of myocardial I/R injury
Mice underwent myocardial I/R surgery as previously
described [30]. Briefly, mice were anesthetized with a
mixture of Fentanyl (Jansen-Cilag) 0.05 mg/kg, Dormicum
(Roche) 5 mg/kg, and medetomidine 0.5 mg/kg through an
intraperitoneal injection. A core body temperature of about
37C was maintained during surgery by continuous moni-
toring with a rectal thermometer and an automatic heating
blanket. Mice were intubated and ventilated (Harvard
Apparatus Inc, Holliston, MA) with 100% oxygen. The
LCA was ligated for 30 min with an 8-0 Ethilon (Ethicon)
suture with a section of polyethylene-10 tubing placed over
the LCA. Ischemia was confirmed by bleaching of the
myocardium and ventricular tachyarrhythmia. Reperfusion
was initiated by release of the ligature and removal of the
polyethylene-10 tubing. In sham-operated animals, the
suture was placed beneath the LCA without ligation.
Reperfusion of the endangered myocardium was charac-
terized by typical hyperemia in the first few minutes. The
chest wall was closed, and the animals subcutaneously
received Antisedan (Pfizer) 2.5 mg/kg, Anexate (Roche)
0.5 mg/kg, and Temgesic (Schering-Plough) 0.1 mg/kg.
CMR protocol
A vertical 9.4 T and 89-mm-diameter bore scanner was
used, equipped with 1,500 mT/m gradients (Bruker Bio-
Spin GmbH, Ettlingen, Germany). Mice were anesthetized
with 1.5–3 vol% isoflurane in a 2:1 mixture of air (0.3 l/
min) and oxygen (0.15 l/min). The mice were put on a
custom-built cradle and positioned inside a 3-cm-diameter
quadrature volume coil. During the CMR examination
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anesthesia was maintained at 1.5–2.5 vol% isoflurane to
keep the respiratory rate at 50–60 bpm. We did not use
ECG leads for cardiac triggering but derived both cardiac
and respiratory motion signals from a pressure pad placed
under the chest of the mouse.
The CMR protocol consisted of the following steps. After
global shimming and RF pulse calibration, 2- and 4-chamber
view scout scans were made to plan a single mid-cavity
short-axis slice. Cine imaging was performed with a retro-
spectively-triggered (self-gated) gradient-echo sequence
[31], with the following parameters: TR = 6.8 ms,
TE = 1.9 ms, number of movie frames = 15, slice
thickness = 1 mm, matrix = 256 9 256, field-of-view =
3 9 3 cm2. Because of the slight difference of hearts size
between mice and the dilation of each heart after infarction,
seven to nine short-axis slices with inter-slice distance of
1 mm and no slice gap were measured to cover the heart from
apex to base. Based on the Cine short-axis images, a mid
axial slice was selected that included an area of remote viable
tissue as well as a substantial infarct area. T2
* mapping was
performed in this slice using a cardiac-triggered multi-gra-
dient-echo sequence with the following parameters:
TR = R–R interval, TE = 1.22, 3.45, 5.68, 7.91, 10.14, and
12.37 ms, slice thickness = 1 mm, matrix = 128 9 128,
field-of-view = 3 9 3 cm2. The trigger delay was chosen in
the mid-diastolic rest period of the heart cycle observed in
the Cine series. The acquisition window of less than 13 ms
resulted in images, which were sufficiently co-registered
for the different echo times to allow for a pixel-wise T2
*
determination (Fig. 1) [32]. LGE scans were performed in
the same slice with a cardiac-triggered inversion-recovery
segmented gradient-echo sequence, with the following
parameters: TR = 5.8 ms, TE = 2.2 ms, number of
segments = 16, slice thickness = 1 mm, matrix = 256 9
256, field-of-view = 3 9 3 cm2. The inversion time (TI)
was optimized to null the signal from remote myocardium
[33, 34]. Gadobutrol (Gadovist, Bayer Schering Pharma AG,
Berlin, Germany) dose of 1 mmol/ml was used. To reduce
volume related variability, contrast agent was diluted 1:4
with a standard saline solution. This dilution resulted in
administered weight-adapted volume of 2 ll/g body weight,
resulting in an equivalent dose of 0.5 mmol/kg body weight
[33]. The contrast agent was injected intravenously through
the tail vein, using a 24-gauge catheter.
CMR data analysis
T2
* maps were generated in Mathematica 7 (Wolfram
Research, Champaign, IL, USA) by pixel-wise fittings of
the multi-gradient-echo signal intensities to the equation
S ¼ S0eTE=T2 . The LV myocardium was manually seg-
mented by drawing epicardial and endocardial contours,
excluding the papillary muscles. LGE-based single-slice
infarct size is reported as percentage of the LV myocardial
cross-sectional area. A region of interest in the infarct in
the myocardial free wall (infarct ROI) was drawn based on
gadolinium enhancement and presence of akinetic myo-
cardium. A second ROI was drawn in the non-enhancing
remote tissue in the septum (remote ROI). For the control
mice, ROIs were drawn in the septum and the free wall.
These ROIs were drawn within the zone free from sus-
ceptibility artifacts induced by lungs. T2
* values are reported
as group average and standard deviation of the mean T2
* in
the ROIs. Cine images were analyzed with Qmass digital
imaging software (Medis, Leiden, The Netherlands). Semi-
automatic segmentation was used to determine end-dia-
stolic volume (EDV), end-systolic volume (ESV), wall
thickness (WT) and systolic wall thickening (SWT).
Ejection fraction (EF) was calculated as 100%(EDV -
ESV)/EDV.
Histopathology
For histological evaluation a 1.5-mm-thick slice containing
infarcted myocardium was fixed in 4% formalin and par-
affin-embedded. Hereafter, 5-lm-thick sections were
mounted on glass slides and stained with Picrosirius red
staining for collagen, Prussian blue staining for iron, and
Hematoxylin-Eosin (HE) for cellular structures. The
stained sections were photographed with a digital image
microscopy using white or polarized light.
Statistical analysis
All statistical analysis was evaluated using (SPSS 17 for
Windows; SPSS). Results were expressed as mean ± stan-
dard deviation for each group of animals. An independent
two-tailed sample t test and the Mann–Whitney exact two-
tailed U test were performed to compare mean values in
subjects for each time point post MI versus baseline. Results
were considered statistically significant for a p value of less
than 0.05. The correlation analysis of T2
* values against WT
was performed using linear regression.
Results
An image series of a mid-axial slice with varying TE for a
representative mouse at baseline is shown in Fig. 1a. The
LV myocardium was well co-registered for the different
images. Signal loss due to susceptibility differences was
occasionally observed for the images with the longest TE.
Pixel-wise fitting of the signal intensities in the LV myo-
cardium as function of TE resulted in a T2
* map as shown in
Fig. 1b. T2
* values were homogeneous throughout the LV
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myocardial wall and consistent between mice, with a mean
T2
* value of 17.1 ± 2.0 ms in the free wall.
Figure 2 displays a collection of images, consisting of
LGE, T2
* maps, and Cine images at diastole, for a repre-
sentative mouse at day 1, 7 and 28 after induction of the
MI. On day 1, LGE resulted in a homogeneous enhance-
ment of the infarct in the mid-anterior and mid-anterolat-
eral wall, whereas on days 7 and 28 enhanced area was
smaller, heterogeneous, and difficult to detect. Corre-
sponding T2
* maps revealed a different picture. At day 1, a
significant change in T2
* could be detected in the LGE-
based infarct area. Further, at days 7 and 28, T2
* dramati-
cally decreased, particularly in the mid-anterolateral region
indicating the existence of a significant infarct. The pres-
ence of an infarct was further corroborated by the Cine
images, which showed increased WT in the mid-anterior
and mid-anterolateral wall at day 1, followed by progres-
sive thinning below baseline levels at days 7 and 28,
respectively.
Figure 3 shows LGE and T2
* maps of one of three
mice with a small infarct in the mid-anterolateral wall,
as indicated by a small area of LGE at day 1. Gado-
linium enhancement could not be detected anymore at
days 7 and 28. In the first group of n = 9 mice with MI,
n = 3 mice displayed this atypical behavior. Presumably,
LGE at day 1 revealed a small area at risk that could not
be detected in the chronic phase. Importantly, T2
* values
in the mid-anterolateral wall also remained unaffected
throughout infarct healing and did not deviate from
baseline values.
Quantitative T2
* values (n = 5 mice, Fig. 4) were
dynamic throughout infarct development. In the infarct,
quantitative T2
* values decreased significantly (p \ 0.05)
from baseline (17.1 ± 2.0 ms) to day 1 (12.0 ± 1.1 ms)
followed by a further decrease (p \ 0.005) both at day 7
(7.9 ± 1.0 ms) and day 28 (6.4 ± 0.7 ms). In addition, the
mid-septal (remote) area showed a significant (p \ 0.05)
decrease of T2
* values from baseline (18.2 ± 2.0 ms) to day
1 (13.9 ± 0.8 ms), then slightly recovered at day 7
(14.2 ± 1.1 ms) and day 28 (15.6 ± 1.0 ms).
Global cardiac function of both infarct and sham-oper-
ated groups was assessed by Cine imaging (Fig. 5a–c). The
infarct group displayed a progressive and significant
increase in EDV and ESV, indicative for a considerable
dilation of the heart due to the infarct. For the sham-
operated group no significant changes in EDV and ESV
upon time after surgery were observed. The infarct group
presented a decline in EF from 54 ± 3% at baseline to
39 ± 2%, 28 days after surgery (Fig. 5c). For the sham-
operated group, EF was slightly elevated at day 1; how-
ever, it normalized at day 7 and 28 after surgery. Group-
averaged (n = 5) infarct sizes from LGE analysis of a mid-
ventricular slice as function of days after surgery are pre-
sented in Fig. 5d. At day 1, LGE revealed an average
infarct size of 41 ± 6%, dropping to 26 ± 3 and 22 ± 4 %
(p \ 0.05, compared to day 1) of the LV area at days 7 and
28, respectively, which could be related to infarct resorp-
tion over time [35].
In the infarct group, WT in the free wall (infarct area)
showed a significant (p \ 0.005) transient increase day 1
after MI, followed by progressive thinning (Fig. 6a).
Decreased WT in the infarct paralleled a decrease of the
quantitative T2
* values (Fig. 4). The mid-septal (remote)
area in the infarct group showed no significant changes in
Fig. 1 Representative series of cardiac images with varying TE and
corresponding T2
* map. a Gradient-echo CMR with varying TE for a
mid-ventricle short-axis slice of a representative mouse at baseline.
b Top signal intensity S in the myocardium as function of TE. The
solid line is an exponential fit to the data. Bottom T2
* map. T2
* in the LV
myocardium at end-diastole is color-coded between 0 and 20 ms
according to the pseudo color scale on the right. The background
image is a regular gradient echo image with TE = 1.22 ms
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WT. In line with the increased WT of the free wall at day 1,
the SWT, as a measure of local systolic function, also
displayed a transient depression 1 day after surgery, only
partially recovering at days 7 and 28 (Fig. 6b). Also, SWT
of the remote area was slightly depressed at all time points
compared to baseline. The sham-operated group revealed
no significant changes in both WT and SWT as function of
days after surgery (Fig. 6c, d). WT in the infarct correlated
positively and significantly with T2
* (Fig. 7). Thus, the
chronic MI is characterized by a lower T2
* value compared
to the acute MI.
Since T2
* changes are related to the structural and com-
positional changes in the infarct myocardial tissue, we
performed histology at each time point after I/R injury.
Figure 8 shows images of three representative mice at day
1, 7 and 28 after MI. Picrosirius staining (Fig. 8a) revealed
no collagen deposits in the infarct area at day 1. At day 7
substantial collagen deposition was observed, followed by
a significant increase at day 28. Sections stained with
Prussian Blue showed scattered spots of iron as early as
1 day after MI (Fig. 8b). Iron deposition became more
prominent at day 7 and further increased at day 28. Finally,
on sections stained with HE (Fig. 8c) the infarct area on
day 1 was characterized by infiltration of inflammatory
cells.
Discussion
In this study we aimed to systematically study quantitative
changes in T2
* of the mouse myocardium up to 28 days post
I/R injury and to evaluate its added value in characterizing
chronic infarcts in comparison to commonly applied LGE
and Cine imaging. Combining different CMR techniques,
if interpreted carefully, are a potential advantage in the
evaluation of the pathophysiological changes in the injured
myocardium. Baseline T2
* values were comparable to T2
values found at 9.4 T [36] and 11.75 T [37], which sug-
gests that decay due to static magnetic field inhomogene-
ities is largely absent in the healthy myocardium. We found
that quantitative T2
* values decreased progressively during
infarct development. Throughout the observation period,
the local decrease of T2
* in the infarct was accompanied by
globally and locally reduced ventricular function (Figs. 4,
5, 6, 7). The reduction in T2
* with infarct age could be
explained by the presence of iron (Fig. 8a) [3, 38]. Addi-
tionally, the formation of significant amounts of collagen
(Fig. 8b) may contribute to the progressive decline of T2
*
with infarct age [29].
LGE imaging is currently unchallenged the gold stan-
dard technique to assess infarct size. Nevertheless, in
certain cases when LGE imaging is inconclusive,
Fig. 2 Mid-ventricle short-axis
slice of a mouse heart at 1, 7,
and 28 days after I/R
myocardial infarction. Left Cine
images at end-diastole. At day 1
wall thickness in the free wall is
increased, whereas at days 7 and
28 the free wall decreased in
thickness. Middle corresponding
T2
* maps color-coded from 0 to
20 ms. T2
* is decreased in the
infarct in the free wall at day 7
and 28 (red arrows). Right
corresponding LGE images.
Yellow arrows point to the
location of the infarct. Infarct
location was confirmed by the
presence of an akinetic area and
locally reduced wall thickening
in Cine imaging
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additional characterization of the infarct by T2
* imaging
could provide complementary information. In the acute
phase after I/R injury LGE-based infarct size may be
inaccurate [39], when there is loss of cell membrane
integrity [16], an inflammatory response [40, 41], necro-
sis, hemorrhage, micro-vascular obstruction (MVO) and
edema. Indeed, for the acute infarcts at day 1 we found a
large LGE-based infarct size accompanied by increased
wall-thickness, suggesting the presence of edema. We did
not observe a transient increase in T2
* at day 1 by the
presence of this edema, as previously observed with
T2-weighted imaging [24]. The effect of edema on T2
* is
apparently lower than the decrease of T2
* induced by iron
or collagen (Fig. 8). This observation is critical in the
clinical setting where early assessment of viability is
significantly hampered by the presence of infarct-induced
edema. T2
*-imaging may be a tool to circumvent this
inevitable problem after acute MI.
In the chronic infarct, the formation of scar tissue could
be responsible for a reduced distribution volume for the
extracellular contrast agent. In turn, reduced distribution
volume leads to an apparent reduction in infarct size and
inhomogeneous enhancement (Figs. 2, 5). Additionally, the
extremely low T2
* in the infarct (Fig. 2), which locally
decreased down to a few milliseconds, could effectively
null the signal of the inversion recovery gradient-echo
sequence with an echo time of 2.2 ms, obscuring the LGE
[42].
At day 1, a significant decrease of T2
* (Fig. 4) and a
transient depression of systolic performance (SWT; Fig. 6)
Fig. 3 T2
* maps and LGE of a
mouse with a small LGE
positive area at day 1 but no
detectable infarct at later days.
LGE showed enhancement in
the mid-anterior wall at day 1
(yellow arrow). Enhancement,
however, was absent at 7 and
28 days. In parallel, T2
* values in
the infarct area were maintained
at baseline levels. T2
* maps
displayed spurious lowering in
areas with no infarct related to
susceptibility artifacts (red
arrows)
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were found not only in the infarct, but also to a lesser
extent in the remote myocardium. This could be a sec-
ondary response in parallel to the structural changes in the
infarct region. These findings are in agreement with those
of Bogaert et al. [43] who observed a dysfunction in the
remote area at 5 ± 2 days after reperfusion in patients with
transmural anterior MI. Others have also shown that
remodeling is initiated in the remote myocardium as early
as 1 day after I/R injury [44–47].
Comparing Figs. 2 and 3 makes an interesting case.
Figure 2 presented an example of a mouse with a con-
siderable infarct at day 1, based on a large LGE positive
area. However, at days 7 and 28, the infarct was difficult
to detect on LGE, from which one could jump to the
conclusion that a considerable part of the area at risk at
day 1 recovered at later time points. However, the T2
*
maps at day 7 and 28 revealed low T2
* values in the
infarct area, indicating that the infarct was not recovered.
The presence of non-viable myocardium (not detected by
LGE) was confirmed by akinesia of that area and locally
suppressed systolic thickening (SWT) in Cine imaging.
Fig. 4 Quantitative T2
* values in the infarct and remote myocardium
at baseline (BL) and up to 28 days after surgery. n = 5 mice,
*significantly different from baseline (p \ 0.05), and **significantly
different from baseline (p \ 0.005)
Fig. 5 Left ventricle functional
parameters and infarct size for
infarct (n = 5) and sham-
operated (n = 8) groups at
baseline (BL) and up to 28 days
after surgery. a End diastolic
volume. b End systolic volume.
c Ejection fraction. d Single-
slice infarct size. *Significantly
different from baseline
(p \ 0.05), and **significantly
different from baseline
(p \ 0.005)
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Figure 3, conversely, showed one of three mice that
presented a small infarct by LGE at day 1, but displayed
no positive enhancement at day 7 and 28. For this mouse
T2
* in the infarct region was preserved during follow-up,
indicating that for this mouse the initial area at risk
recovered at later time points, as confirmed by healthy
LV function. Thus, T2
* is able to provide additional
information, complementary to LGE, about the myocar-
dial viability after infarction. Taken together, these
findings suggest that T2
* can be used as a surrogate
marker for myocardial recovery during follow-up after
MI.
A limitation to the use of T2
* as a diagnostic marker
for myocardial injury is contamination of intrinsic T2
*
values by the presence of macroscopic susceptibility
differences, mainly present at the air-lung interfaces [26,
27]. Occasionally, we observed lowered T2
* values at the
lung-heart interface (see for example Fig. 3) in areas
with no infarct and no wall-motion abnormalities. Esti-
mations of infarct sizes on the basis of T2
* reduction were
therefore inaccurate. Also the orientation of the heart
with respect to the magnetic field could alter absolute T2
*
values. Improvements in local shimming techniques
might alleviate some of these susceptibility contamina-
tions. Still, use of T2
* mapping as a stand-alone technique
without the complementary information from LGE is
undesired.
Fig. 6 Regional wall thickness
(WT) and systolic wall
thickening (SWT) for infarct
(n = 5) and sham-operated
(n = 8) groups. a WT for
infarct group in remote and
infarct wall. b SWT for infarct
group in remote and infarct
wall. c WT for sham-operated
group in septal and free wall.
d SWT for sham-operated group
in septal and free wall.
*Significantly different from
baseline (p \ 0.05), and
**significantly different from
baseline (p \ 0.005)
Fig. 7 Correlation between infarct wall thickness (WT) and T2
*
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Conclusions
Imaging of the myocardium with a T2
*-mapping technique
in a mouse model of myocardial I/R injury provides useful
and complementary information to LGE and Cine imaging.
The changes of the T2
* were associated with the infarct age,
reversibility of the injury, and gave an indication of the
structural variation in the myocardium throughout infarct
maturation. T2
* decrease in the infarcts was associated with
iron and collagen depositions. In cases where LGE was
inconclusive, T2
* mapping was able to confirm the presence
of a chronic myocardial scar in mice. Taken together, T2
*
mapping may provide important additional information on
myocardial viability in the acute and chronic phase and
scar maturation after acute MI.
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